Ambiq Micro, Inc. (AMBQ) Company Overview

Ambiq Micro, Inc. is an Austin-based fabless semiconductor company listed on the New York Stock Exchange under AMBQ. It designs ultra-low-power systems-on-chip, microcontrollers, real-time clocks, and software for battery-powered edge devices such as wearables, medical sensors, smart-home products, and industrial monitors.

The official mission and company overview emphasize enabling intelligence through low-power semiconductors. Power determines whether AI can run continuously, data can stay local, and small devices can operate longer between charges.

Why does edge AI need Ambiq’s type of technology?

Edge AI must operate within tight thermal, memory, and battery limits. Ambiq says its SPOT platform, architecture, software, and mature-node manufacturing deliver useful compute at lower power. Its 2025 annual report states that its designs consume two to five times less power than traditional alternatives and that more than 80% of 2025 shipments ran AI algorithms.

Ambiq sells semiconductor products rather than subscriptions. Revenue depends on unit volume, average selling price, and product mix. Newer Apollo platforms can command more value through added compute, graphics, connectivity, security, and AI capability, while older products face declining semiconductor prices.

Which revenue streams are economically most important?

Ambiq reports one operating segment and does not disclose separate revenue or profit for Apollo SoCs, Artasie clocks, software, or end markets. Its product portfolio is broad, but most revenue still comes from personal devices, so a few wearable design wins can materially move results.

What does the geographic mix reveal?

Ambiq discloses shipment destinations rather than only ultimate customer locations. In FY2025, China represented $30.7 million of ship-to revenue, Taiwan $25.8 million, Singapore $7.3 million, and the rest of the world $8.7 million. Ultimate Mainland China customers generated only $6.2 million, about 9%, because distributors may sit elsewhere in the channel.

The strategy combines migration to higher-value Apollo platforms with expansion beyond personal devices. In May 2026, management expected non-personal-device sales to double in 2026 versus 2025. That guidance identifies the central diversification milestone.

The Q1 2026 earnings release and March 2026 Form 10-Q show rapid growth with spending still ahead of revenue. Sales rose to $25.1 million from $15.7 million through product ramps, pricing, and a new major customer; more than 80% of units ran AI algorithms.

Where did the growth come from?

Customer concentration improved but remains high: the top three end customers generated 71% of Q1 2026 sales, down from 86% in Q1 2025. Management’s May outlook called for Q2 2026 net sales of $31.0 million to $32.0 million, non-GAAP gross margin of 45.0% to 46.0%, and non-GAAP operating expense of $21.0 million to $22.0 million. Those figures are forward-looking benchmarks until the company reports the quarter.

Ambiq progressed from low-power real-time clocks to microcontrollers, integrated SoCs, AI software, and public capital markets. Each step expanded the addressable workload while preserving power efficiency as the core proposition.

1. 2010
   Ambiq was founded around sub-threshold semiconductor operation, establishing the SPOT technology base that still defines the moat.
2. 2012–2014
   The first real-time clock launched in 2012, and the one-millionth RTC shipped in 2014, proving commercial demand for extreme power efficiency.
3. 2015–2017
   The first SPOT microcontroller launched with claimed tenfold lower power, followed by the second Apollo generation and neural-network deployment.
4. 2018–2020
   Apollo became a system-on-chip platform; by 2020 Ambiq had sold its 100-millionth product and sampled the fourth Apollo generation.
5. 2022–2024
   Apollo4 gained adoption among major wearable manufacturers, while Apollo510 advanced the platform toward more demanding on-device AI.
6. 2025
   Ambiq surpassed 290 million devices, listed on the NYSE on July 30, and used public capital to accelerate R&D and commercial expansion.
7. 2026
   The company reported strong Q1 growth, expanded its HELIA AI software platform, and completed a June public offering that raised $179.4 million in gross proceeds.

Why are the IPO and subsequent offerings strategically important?

Semiconductor product cycles require heavy spending before revenue arrives. Ambiq completed its IPO in July 2025, a January 2026 follow-on that generated $75.3 million of net proceeds, and an upsized June 2026 offering of 2.3 million shares at $78.00 per share. The June offering announcement reported $179.4 million of gross proceeds.

SPOT, patents, and mature process nodes

SPOT operates transistors at sub-threshold and near-threshold voltages, supported by architecture techniques that reduce power further. At January 14, 2026, Ambiq owned 57 issued U.S. patents, 11 foreign patents, 13 pending U.S. applications, and six pending foreign applications. U.S. expirations generally begin from 2033 through 2042.

Ambiq uses TSMC process nodes from 180 to 12 nanometers rather than relying only on leading-edge manufacturing. Its thesis is that architecture, not merely transistor shrinkage, creates the power advantage—important where device cost matters alongside performance.

Full-stack tools and design-win relationships

The moat extends beyond silicon. Apollo hardware, neuralSPOT, HELIA software, development kits, security, connectivity, and graphics form a fuller solution. Early work with OEM and ODM engineers creates switching costs once software, power budgets, and validation are built around a chip. More than 300 million shipped devices demonstrate commercial validation.

Ambiq competes against vendors with broader catalogs, larger engineering teams, established distribution, and greater resources. Its 2025 annual report names Infineon, Microchip, NXP, Silicon Laboratories, STMicroelectronics, Texas Instruments, Nordic Semiconductor, Renesas, Synaptics, and Qualcomm.

How should Ambiq’s market position be framed?

Customer and supplier concentration are the key vulnerabilities

The top five end customers represented 91% of FY2025 sales; the largest three contributed about 36%, 29%, and 20%. TSMC is the sole wafer supplier, without a long-term capacity guarantee. Large customers therefore influence pricing and timing, while one foundry controls critical capacity.

The 2025 annual report shows better product economics despite lower sales. Revenue fell from $76.1 million to $72.5 million, but gross profit rose from $24.3 million to $32.1 million and gross margin expanded from 31.9% to 44.3%. End-customer sales outside Mainland China reached $66.3 million, versus $6.2 million inside.

Can Ambiq fund its growth without debt?

At March 31, 2026, current assets were $241.7 million versus $20.6 million of current liabilities, and equity was $235.2 million. Q1 operating cash use was $11.2 million, intangible purchases were $3.4 million, and property, equipment, and software purchases were $0.6 million. Liquidity was ample, but operations were not self-funding.

Capital allocation is currently growth-oriented: R&D, intellectual property, software, customer support, inventory, and public-company infrastructure take priority over dividends or buybacks. For analysis, the critical question is whether this capital produces scalable gross profit faster than operating expenses and share count expand.

Ambiq has one common share class with one vote per share. The 2026 proxy reported 21,364,914 shares outstanding on April 13, 2026. The table predates the June issuance of 2.3 million shares, so later ownership percentages would generally be lower.

What does the board structure signal?

Esaka has served as CEO since December 2015, while founder Scott Hanson has remained CTO since 2013. The pairing combines technical continuity with operating leadership. Q1 2026 stock-based compensation rose to $3.4 million from $0.9 million, making both cash expenses and dilution-adjusted economics important.

A DCF should not start with mature-semiconductor margins. Ambiq is loss-making, concentrated, and financing growth with equity. Value depends on repeatable revenue growth, sustainable mid-40% or higher gross margin, and operating expenses growing more slowly than gross profit.

Where could upside come from?

Which risks could break the thesis?

A valuation model should tie growth to design-win ramps, margin to product mix and manufacturing efficiency, and expenses to the R&D required for future products. Free cash flow should include physical capex plus acquired IP and software, while share-count assumptions should reflect compensation and 2026 offerings. Update inputs through Ambiq’s official filings page.